Hyperkalemia and management of renin-angiotensin-aldosterone system inhibitors in chronic heart failure with reduced ejection fraction: A systematic review

Hyperkalemia and management of renin-angiotensin-aldosterone system inhibitors in chronic heart failure with reduced ejection fraction: A systematic review

Show other versions (1)

Introduction and Objectives: Renin-angiotensin-aldosterone system inhibitors (RAASi) are the cornerstone of treatment of heart failure with reduced ejection fraction (HFrEF). RAASi optimization in real-life care is challenged by hyperkalemia, a potentially fatal adverse event, which can necessitate...

Full description

Bibliographic Details
Main Authors: Cândida Fonseca, Dulce Brito, Patrícia Branco, João Miguel Frazão, José Silva-Cardoso, Paulo Bettencourt
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Revista Portuguesa de Cardiologia (English Edition)
Subjects:
Tomada de decisão clínica
Resultados clínicos
Terapêutica medicamentosa
Insuficiência cardíaca
Hipercaliemia
Inibidores do sistema renina-angiotensina-aldosterona
Online Access:http://www.sciencedirect.com/science/article/pii/S2174204920303196

Internet

http://www.sciencedirect.com/science/article/pii/S2174204920303196

Similar Items